Ahmed Shaaban1, Amro Al Hajali1, Orwa Elaiwy2, Ahmed El Sotouhy3,4, Issam Al-Bozom2,4, Ali Ayyad1,4,5. 1. Department of Neurosurgery, Hamad Medical Corporation, Doha, Qatar. 2. Department of Pathology, Hamad Medical Corporation, Doha, Qatar. 3. Department of Radiology, Hamad Medical Corporation, Doha, Qatar. 4. Departments of Neurosurgery, Radiology and Pathology, Weill Cornell Medical College, Doha, Qatar. 5. Department of Neurosurgery, Saarland University Hospital, Homburg, Germany.
Abstract
Atypical teratoid rhabdoid tumor (ATRT) is a rare primary malignant tumor of the central nervous system. Little knowledge is available about natural history, behavior, prognosis, and best management guidelines of such tumor. Its occurrence in adults is very rare and more predominant in females. Locations in adults are mainly cerebral hemispheres, but recently, more cases are reported in sellar/suprasellar cisterns. We are reporting a case of purely suprasellar ATRT of a middle aged male who presented initially with diabetes insipidus (DI). Copyright:
Atypical teratoid rhabdoid tumor (ATRT) is a rare primary malignant tumor of the central nervous system. Little knowledge is available about natural history, behavior, prognosis, and best management guidelines of such tumor. Its occurrence in adults is very rare and more predominant in females. Locations in adults are mainly cerebral hemispheres, but recently, more cases are reported in sellar/suprasellar cisterns. We are reporting a case of purely suprasellar ATRT of a middle aged male who presented initially with diabetes insipidus (DI). Copyright:
Atypical teratoid rhabdoid tumor (ATRT) is a rare primary malignant tumor of the central nervous system. It occurs mainly in children below 3 years old in posterior fossa.[1] To our knowledge, about fifty cases are reported in adult population, mainly in females. The cases reported in sellar/suprasellar region have a sellar component with suprasellar extension.[2] According to the World Health Organization classification of central nervous system tumors 2016, ATRT is Grade 4. Diagnosis is mainly pathological through immunohistochemistry either by alterations or loss of integrase interactor 1 (INI1) protein or BRG1 protein.[3] Due to limited number of reported cases, little knowledge is available about natural history, behavior, prognosis, and best management guidelines of such tumor. Hence, we present a unique case of purely suprasellar ATRT without sellar component. We are reporting a case of purely suprasellar ATRT of a middle aged male who presented initially with diabetes insipidus (DI).
Case Report
A 46-year-old male presented with sudden-onset anorexia, nausea, fatigue, dry mouth, thirst, polyuria, polydipsia, and dizziness on standing for 10 days. There was no other complaint. On examination, the patient was confused Glasgow Coma Scale 14, dry mouth, dry tongue, bitemporal hemianopia, moving all limbs. Workup found increased urine output (more than 3 L/day), high serum sodium (159 mmol/L), high serum osmolarity (356 mosm/kg) with relatively low urine osmolarity (125 mosm/kg), and high creatinine (160 μmol/L) (acute kidney injury due to dehydration) which improved after few days of proper hydration. Hormonal profile revealed panhypopituitarism. Radiological images revealed [Figure 2a and b] suprasellar mass lesion. The patient was diagnosed as a case of central diabetes insipidus with panhypopituitarism. He was started on desmopressin, hydrocortisone, and thyroxine which resulted in improvement of his symptoms, signs, and sodium levels.
Figure 2
(a) Axial DWI, T1 pre and post IV contrast, CISS, T2 and FLAIR WI MR images of the brain showing midline intracranial extra-axial mass lesion centered on the supra-sellar cistern of intermediate signal intensity in T1 and T2 WI and relatively high signal intensity in FLAIR WI that shows intense non-homogenous post contrast enhancement pattern as well as evidence of restricted diffusion pattern that indicates high cellularity of the lesion. The differential diagnosis includes germ cell tumor, hypothalamic glioma, meningioma and atypical teratoma. (b) Sagittal and Coronal thin sellar section T2 and T1 WI before and after IV contrast administration clearly showing the lesion in the supra-sellar region indenting the floor of the third ventricle and being separable from the pituitary gland and optic chiasm. (c) 1st day Post-operative MR imaging in Axial T2, FLAIR and T1 pre and post IV contrast, Sagittal and Coronal Thin sellar sections in T1 WI pre and post IV contrast showing almost total resection of the mass lesion with expected post-operative changes; histopathological diagnosis of Atypical Teratoid Rhabdoid tumor (ATRT) was given and the patient was referred to medical oncology care.
(a,b) visual field examination of left eye on the left side and right eye on the right side(a) Axial DWI, T1 pre and post IV contrast, CISS, T2 and FLAIR WI MR images of the brain showing midline intracranial extra-axial mass lesion centered on the supra-sellar cistern of intermediate signal intensity in T1 and T2 WI and relatively high signal intensity in FLAIR WI that shows intense non-homogenous post contrast enhancement pattern as well as evidence of restricted diffusion pattern that indicates high cellularity of the lesion. The differential diagnosis includes germ cell tumor, hypothalamic glioma, meningioma and atypical teratoma. (b) Sagittal and Coronal thin sellar section T2 and T1 WI before and after IV contrast administration clearly showing the lesion in the supra-sellar region indenting the floor of the third ventricle and being separable from the pituitary gland and optic chiasm. (c) 1st day Post-operative MR imaging in Axial T2, FLAIR and T1 pre and post IV contrast, Sagittal and Coronal Thin sellar sections in T1 WI pre and post IV contrast showing almost total resection of the mass lesion with expected post-operative changes; histopathological diagnosis of Atypical Teratoid Rhabdoid tumor (ATRT) was given and the patient was referred to medical oncology care.Ophthalmology examination preoperative revealed visual acuity 6/9 aided (glasses) in both eyes [Figure 1a and b].
Figure 1
(a,b) visual field examination of left eye on the left side and right eye on the right side
After stabilization of patient medical conditions, he underwent right supraorbital craniotomy and resection of suprasellar lesion [Figure 5a and b]. Frozen section intraoperative was suggestive of high-grade malignant lesion. Final pathology revealed ATRT [Figures 3 and 4a-d]. Postoperative day 1, magnetic resonance imaging showed almost total resection of the tumor [Figure 2c].
Figure 5
(a) Microscopic images showing right supraorbital craniotomy approach and resection of suprasellar lesion (atypical teratoid/rhabdoid tumor) yellow star: Dura, green star: Right optic nerve, red star: Internal carotid artery black arrow atypical teratoid rhabdoid tumor. (b) Endoscopic images showing right supraorbital craniotomy approach and resection of suprasellar lesion (atypical teratoid/ rhabdoid tumor)
Figure 3
Microscopic view showing sheets of rhabdoid cells with dense eosinophilic inclusion-like cytoplasm (H&E ×400)
Figure 4
(a)Tumor cells are diffusely positive with epithelial membrane antigen (EMA), (immunohistochemistry ×200) (b) Tumor cells are significantly positive with cytokeratin AE1/AE3) (immunohistochemistry ×200) (c) Tumor cells are focally expressing glial fibrillary acidic protein (GFAP) (immunohistochemistry ×400) (d) Loss of nuclear staining by INI-1 while blood vessels show retained nuclear staining (immunohistochemistry ×400)
Microscopic view showing sheets of rhabdoid cells with dense eosinophilic inclusion-like cytoplasm (H&E ×400)(a)Tumor cells are diffusely positive with epithelial membrane antigen (EMA), (immunohistochemistry ×200) (b) Tumor cells are significantly positive with cytokeratin AE1/AE3) (immunohistochemistry ×200) (c) Tumor cells are focally expressing glial fibrillary acidic protein (GFAP) (immunohistochemistry ×400) (d) Loss of nuclear staining by INI-1 while blood vessels show retained nuclear staining (immunohistochemistry ×400)(a) Microscopic images showing right supraorbital craniotomy approach and resection of suprasellar lesion (atypical teratoid/rhabdoid tumor) yellow star: Dura, green star: Right optic nerve, red star: Internal carotid artery black arrow atypical teratoid rhabdoid tumor. (b) Endoscopic images showing right supraorbital craniotomy approach and resection of suprasellar lesion (atypical teratoid/ rhabdoid tumor)The case was discussed in a multidisciplinary meeting and planned for adjuvant chemoradiotherapy.
Pathological description of atypical teratoid/rhabdoid tumor
Sections show highly cellular tumor consisting of sheets, nests, and papillary structures. The tumor cells have heterogeneous morphology, in some areas they appear small primitive, while in others, they appear large polygonal with abundant dense eosinophilic cytoplasm, and in most of the areas, they have rhabdoid appearance with eccentrically placed vesicular nuclei, prominent nucleoli, and abundant eosinophilic inclusion-like cytoplasm [Figure 3]. By immunohistochemistry, tumor cells show immunophenotypic heterogeneity characterized by positivity with epithelial membrane antigen [Figure 4a], cytokeratin AE1/AE3 [Figure 4b], glial fibrillary acidic protein [Figure 4c], S100, smooth muscle actin, Olig2, synaptophysin, and vimentin, but most importantly, they show loss of nuclear staining by INI1 [Figure 4d].
Discussion
ATRT is embryonal tumors containing rhabdoid component (eccentric round nuclei, large cell body, small-to-medium size nucleoli, and open chromatin) in addition to primitive neuroectodermal, mesenchymal, epithelial features. It was first described 1978 in the kidneys. Brain tumors similar to primitive neuroectodermal tumor with rhabdoid component were first described 1987 and named “atypical teratoid tumors of infancy.“[1] Diagnosis is mainly pathological through immunohistochemistry either by alterations or loss of INI1 protein or BRG1 protein in addition to rhabdoid components.[13]Based on our literature review, only fifty cases are reported in adults, with more than two-third of cases in females.[3] The average age of diagnosis is 36.7.[3] The most common locations include cerebral hemispheres and sellar/suprasellar regions. To our knowledge, all reported cases in sellar/suprasellar regions occurred in females and all of them have sellar component with suprasellar extension.[245678910111213141516] Our case is the first reported case to occur in middle-aged males with purely suprasellar location without any sellar components. Intraoperative lesion appeared to be arising from hypothalamus. Hence, it can direct research toward pathogenesis and origins of such tumors.Clinical presentation varies based on patient age, location, and tumor size. All cases reported in sellar/suprasellar region presented mainly with headache and diplopia.[245678910111213141516] Two of the reported cases presented with subarachnoid hemorrhage associated with intraventricular extension.[211] As our case is purely suprasellar (hypothalamic) with compression of pituitary stalk, so presentation was a little bit different as diabetes insipidus and panhypopituitarism.We preferred right supraorbital craniotomy approach based on many reasons. First, it is a minimally invasive approach. Second, exposure is almost similar to other approaches (pterional and interhemispheric). Third, you can work in different windows including interoptic window, carotico-optic window, translamina terminalis, and lateral to carotid window. In addition, our surgery included both microscopic and endoscopic techniques. Putting in mind, you do not have to manipulate the optic nerve in supraorbital approach. Right supraorbital approach is preferred as it is nondominant hemisphere, and we can decompress optic nerve as there is more deficit on right side. On the other hand, interhemispheric approach not superior to supraorbital approaches, it gives you access only to midline windows including interoptic window and translamina terminalis but not lateral to carotid window.[1718]Based on genetic studies, ATRT arises as a result of chromosome 22 deletion including area INI1/hSNF5 tumor suppressor gene required to suppress rhabdoid tumor.[119] There is still no agreement about the best management guidelines. However, like our case, treatment started with surgical resection followed by chemoradiotherapy.[2]Prognosis is poor, and majority of sellar/suprasellar cases die within 2 years of diagnosis.[2] There is no previous case as purely suprasellar (hypothalamic). Thus, we have no data about the prognosis of purely suprasellar lesions.ATRT is rarely considered in the differential diagnosis either radiologically, intraoperative. Preoperative radiological differential diagnoses were germ cell tumor, hypothalamic glioma, meningioma, and atypical teratoma. Our impression intraoperative was high-grade glioma arising either from optic chiasm or hypothalamus. Fresh frozen sample sent for pathology intraoperative and impression was highly malignant lesion either glioma or metastasis. On the contrast, final pathology report was ATRT.Therefore, we should to start consider ATRT in our differential diagnosis for suprasellar lesions as it will affect our management either early surgical intervention for resection and pathological diagnosis or follow-up with serial imaging. More basic and clinical research is needed on multicenter level as a number of cases are limited to address issues of natural history, behavior, radiological distinguishing specific features, prognosis, and management strategy.
Conclusion
Our case is the first reported purely suprasellar (hypothalamic) ATRT without sellar component in an adult male. We should consider ATRT in our differential diagnosis of suprasellar lesions. We recommend gross total resection of such malignant lesion followed by chemoradiotherapy. Reevaluation of our understanding of pathogenesis and molecular genetics should be done to broaden our knowledge about actual origin of these tumors. More research is needed to address natural history, behavior, radiological distinguishing specific features, prognosis, and management strategy.
Authors: T M Schneiderhan; K Beseoglu; M Bergmann; U Neubauer; S Macht; D Hänggi; G Reifenberger; M J Riemenschneider Journal: Neuropathol Appl Neurobiol Date: 2011-04 Impact factor: 8.090
Authors: Jonathan Rychen; Davide Croci; Michel Roethlisberger; Erez Nossek; Matthew Potts; Ivan Radovanovic; Howard Riina; Luigi Mariani; Raphael Guzman; Daniel W Zumofen Journal: World Neurosurg Date: 2018-02-13 Impact factor: 2.104
Authors: Jack Raisanen; Jaclyn A Biegel; Kimmo J Hatanpaa; Alexander Judkins; Charles L White; Arie Perry Journal: Brain Pathol Date: 2005-01 Impact factor: 6.508
Authors: Costanzo Moretti; Domenico Lupoi; Francesca Spasaro; Laura Chioma; Paola Di Giacinto; Martina Colicchia; Mario Frajoli; Renzo Mocini; Salvatore Ulisse; Manila Antonelli; Felice Giangaspero; Lucio Gnessi Journal: Clin Med Insights Case Rep Date: 2013-11-27